United States Viral Clearance Market Report 2016

United States Viral Clearance Market Report 2016

1 Viral Clearance Overview

1.1 Product Overview and Scope of Viral Clearance

1.2 Classification of Viral Clearance

1.2.1 Viral Detection Method

1.2.2 Viral Removal Method

1.2.3 Viral Inactivation Method

1.3 Application of Viral Clearance

1.3.1 Blood & Blood Products

1.3.2 Cellular & Gene Therapy Products

1.3.3 Stem Cell Products

1.3.4 Tissue & Tissue Products

1.3.5 Vaccines and Therapeutics

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Viral Clearance (2011-2021)

1.4.1 United States Viral Clearance Sales and Growth Rate (2011-2021)

1.4.2 United States Viral Clearance Revenue and Growth Rate (2011-2021)

2 United States Viral Clearance Competition by Manufacturers

2.1 United States Viral Clearance Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Viral Clearance Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Viral Clearance Average Price by Manufactures (2015 and 2016)

2.4 Viral Clearance Market Competitive Situation and Trends

2.4.1 Viral Clearance Market Concentration Rate

2.4.2 Viral Clearance Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Viral Clearance Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Viral Clearance Sales and Market Share by Type (2011-2016)

3.2 United States Viral Clearance Revenue and Market Share by Type (2011-2016)

3.3 United States Viral Clearance Price by Type (2011-2016)

3.4 United States Viral Clearance Sales Growth Rate by Type (2011-2016)

4 United States Viral Clearance Sales (Volume) by Application (2011-2016)

4.1 United States Viral Clearance Sales and Market Share by Application (2011-2016)

4.2 United States Viral Clearance Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Viral Clearance Manufacturers Profiles/Analysis

5.1 Avance Biosciences Inc. (U.S.)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Viral Clearance Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Avance Biosciences Inc. (U.S.) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 BSL BIOSERVICE (Germany)

5.2.2 Viral Clearance Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 BSL BIOSERVICE (Germany) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Clean Cells (France)

5.3.2 Viral Clearance Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Clean Cells (France) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Charles River Laboratories International, Inc. (U.S.)

5.4.2 Viral Clearance Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Charles River Laboratories International, Inc. (U.S.) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Lonza Group (Switzerland)

5.5.2 Viral Clearance Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Lonza Group (Switzerland) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Merck KGaA (Germany)

5.6.2 Viral Clearance Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Merck KGaA (Germany) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Sigma-Aldrich Corporation (U.S.)

5.7.2 Viral Clearance Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Sigma-Aldrich Corporation (U.S.) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 SGS S.A. (Switzerland)

5.8.2 Viral Clearance Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 SGS S.A. (Switzerland) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Texcell, Inc. (France)

5.9.2 Viral Clearance Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Texcell, Inc. (France) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 WuXi PharmaTech (Cayman)

5.10.2 Viral Clearance Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 WuXi PharmaTech (Cayman) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

6 Viral Clearance Manufacturing Cost Analysis

6.1 Viral Clearance Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Viral Clearance

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Viral Clearance Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Viral Clearance Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Viral Clearance Market Forecast (2016-2021)

10.1 United States Viral Clearance Sales, Revenue Forecast (2016-2021)

10.2 United States Viral Clearance Sales Forecast by Type (2016-2021)

10.3 United States Viral Clearance Sales Forecast by Application (2016-2021)

10.4 Viral Clearance Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Viral Clearance

Table Classification of Viral Clearance

Figure United States Sales Market Share of Viral Clearance by Type in 2015

Figure Viral Detection Method Picture

Figure Viral Removal Method Picture

Figure Viral Inactivation Method Picture

Table Application of Viral Clearance

Figure United States Sales Market Share of Viral Clearance by Application in 2015

Figure Blood & Blood Products Examples

Figure Cellular & Gene Therapy Products Examples

Figure Stem Cell Products Examples

Figure Tissue & Tissue Products Examples

Figure Vaccines and Therapeutics Examples

Figure United States Viral Clearance Sales and Growth Rate (2011-2021)

Figure United States Viral Clearance Revenue and Growth Rate (2011-2021)

Table United States Viral Clearance Sales of Key Manufacturers (2015 and 2016)

Table United States Viral Clearance Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Viral Clearance Sales Share by Manufacturers

Figure 2016 Viral Clearance Sales Share by Manufacturers

Table United States Viral Clearance Revenue by Manufacturers (2015 and 2016)

Table United States Viral Clearance Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Viral Clearance Revenue Share by Manufacturers

Table 2016 United States Viral Clearance Revenue Share by Manufacturers

Table United States Market Viral Clearance Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Viral Clearance Average Price of Key Manufacturers in 2015

Figure Viral Clearance Market Share of Top 3 Manufacturers

Figure Viral Clearance Market Share of Top 5 Manufacturers

Table United States Viral Clearance Sales by Type (2011-2016)

Table United States Viral Clearance Sales Share by Type (2011-2016)

Figure United States Viral Clearance Sales Market Share by Type in 2015

Table United States Viral Clearance Revenue and Market Share by Type (2011-2016)

Table United States Viral Clearance Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Viral Clearance by Type (2011-2016)

Table United States Viral Clearance Price by Type (2011-2016)

Figure United States Viral Clearance Sales Growth Rate by Type (2011-2016)

Table United States Viral Clearance Sales by Application (2011-2016)

Table United States Viral Clearance Sales Market Share by Application (2011-2016)

Figure United States Viral Clearance Sales Market Share by Application in 2015

Table United States Viral Clearance Sales Growth Rate by Application (2011-2016)

Figure United States Viral Clearance Sales Growth Rate by Application (2011-2016)

Table Avance Biosciences Inc. (U.S.) Basic Information List

Table Avance Biosciences Inc. (U.S.) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Avance Biosciences Inc. (U.S.) Viral Clearance Sales Market Share (2011-2016)

Table BSL BIOSERVICE (Germany) Basic Information List

Table BSL BIOSERVICE (Germany) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

Table BSL BIOSERVICE (Germany) Viral Clearance Sales Market Share (2011-2016)

Table Clean Cells (France) Basic Information List

Table Clean Cells (France) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

Table Clean Cells (France) Viral Clearance Sales Market Share (2011-2016)

Table Charles River Laboratories International, Inc. (U.S.) Basic Information List

Table Charles River Laboratories International, Inc. (U.S.) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

Table Charles River Laboratories International, Inc. (U.S.) Viral Clearance Sales Market Share (2011-2016)

Table Lonza Group (Switzerland) Basic Information List

Table Lonza Group (Switzerland) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lonza Group (Switzerland) Viral Clearance Sales Market Share (2011-2016)

Table Merck KGaA (Germany) Basic Information List

Table Merck KGaA (Germany) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck KGaA (Germany) Viral Clearance Sales Market Share (2011-2016)

Table Sigma-Aldrich Corporation (U.S.) Basic Information List

Table Sigma-Aldrich Corporation (U.S.) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sigma-Aldrich Corporation (U.S.) Viral Clearance Sales Market Share (2011-2016)

Table SGS S.A. (Switzerland) Basic Information List

Table SGS S.A. (Switzerland) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

Table SGS S.A. (Switzerland) Viral Clearance Sales Market Share (2011-2016)

Table Texcell, Inc. (France) Basic Information List

Table Texcell, Inc. (France) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

Table Texcell, Inc. (France) Viral Clearance Sales Market Share (2011-2016)

Table WuXi PharmaTech (Cayman) Basic Information List

Table WuXi PharmaTech (Cayman) Viral Clearance Sales, Revenue, Price and Gross Margin (2011-2016)

Table WuXi PharmaTech (Cayman) Viral Clearance Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Viral Clearance

Figure Manufacturing Process Analysis of Viral Clearance

Figure Viral Clearance Industrial Chain Analysis

Table Raw Materials Sources of Viral Clearance Major Manufacturers in 2015

Table Major Buyers of Viral Clearance

Table Distributors/Traders List

Figure United States Viral Clearance Production and Growth Rate Forecast (2016-2021)

Figure United States Viral Clearance Revenue and Growth Rate Forecast (2016-2021)

Table United States Viral Clearance Production Forecast by Type (2016-2021)

Table United States Viral Clearance Consumption Forecast by Application (2016-2021)